In recent years, polysaccharides-based nanocomposites have been used for biomedical applications. In the current study, a nanocomposite based on myco-synthesized copper nanoparticles (CuNPs) and starch was prepared. The prepared nanocomposite was fully characterized using UV-visible spectroscopy (UV-vis), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM), energy-dispersive X-ray spectroscopy (EDX), mapping, transmission electron microscope (TEM), and dynamic light scattering (DLS). Results revealed that this nanocomposite is characterized by nano spherical shape ranged around 200 nm as well as doped with CuNPs with size about 9 nm. Antimicrobial, antioxidant, and anticancer activities of the prepared nanocomposite were evaluated. Results revealed that CuNPs-based nanocomposite exhibited outstanding antibacterial and antifungal activity toward Escherichia coli ATCC25922, Bacillus subtilis ATCC605, Candida albicans ATCC90028, Cryptococcus neoformance ATCC 14,116, Aspergillus niger RCMB 02,724, A. terreus RCMB 02,574, and A. fumigatus RCMB 02,568. Moreover, CuNPs-based nanocomposite has a strong antioxidant activity as compared to ascorbic acid, where IC50 was 18 µg/mL. Cytotoxicity test of CuNPs-based nanocomposite revealed that this nanocomposite is safe in use, where IC50 was 185.1 µg/mL. Furthermore, CuNPs-based nanocomposite exhibited potential anticancer activity against MCF7 cancerous cell line where IC50 was 62.8 µg/mL which was better than CuNPs alone. In conclusion, the prepared CuNPs with starch-based nanocomposite is promising for different biomedical applications as antimicrobial, antioxidant, and anticancer activities.
Keywords: Anticancer activity; Antimicrobial activity; Copper nanoparticles; Nanocomposite; Starch.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.